-
Product Insights
Narcolepsy – Drugs In Development, 2023
Global Markets Direct’s, ‘Narcolepsy - Drugs In Development, 2023’, provides an overview of the Narcolepsy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Narcolepsy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Sector Analysis
Narcolepsy Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Narcolepsy Marketed and Pipeline Drugs Report Overview Narcolepsy is a chronic disorder that is mainly characterized by excessive daytime sleepiness and, in the majority of individuals, cataplexy—a sudden loss of muscle tone during wakefulness that is evoked by strong, usually positive, emotions. Patients with narcolepsy can also experience disturbed nighttime sleep, sleep paralysis, hypnagogic hallucinations, or hypnopompic hallucinations. Narcolepsy marketed and pipeline drugs market research report report includes an assessment of the disease epidemiology, leading marketed products with sales forecast,...